Estimated reading time: 1 minutes
One of the largest-ever studies on the topic of deprescribing medications shows the potential promise, and pitfalls, of a massive effort to reduce overuse of a common class of heartburn medications known as proton pump inhibitors or PPIs. It also reveals that some of the feared risks from PPIs may be overblown.
About The Author
Discover more from Life is Pro-Mazing!
Subscribe to get the latest posts sent to your email.